pISSN 1738-6586   eISSN 2005-5013
Open Access, Peer-reviewed
    J Clin Neurol. 2012 Sep;8(3):190-197. English.
    Published online Sep 27, 2012.
    https://doi.org/10.3988/jcn.2012.8.3.190
    Copyright © 2012 Korean Neurological Association
    Original Article

    The Effect of Cognitive Training in Patients with Mild Cognitive Impairment and Early Alzheimer's Disease: A Preliminary Study

    Hye Ran Hwang,a Seong Hye Choi,a Dae Hyun Yoon,b Byung-Nam Yoon,a,c Young Ju Suh,d DaeHyung Lee,e Im-Tae Han,a and Chang-Gi Honga
      • aDepartment of Neurology, Inha University School of Medicine, Incheon, Korea.
      • bDepartment of Psychiatry, Seoul National University College of Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
      • cDepartment of Neurology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
      • dClinical Research Institute, Inha University School of Medicine, Incheon, Korea.
      • eClinical Trial Center, Inha University Hospital, Incheon, Korea.
    • Correspondence: Seong Hye Choi, MD, PhD. Department of Neurology, Inha University School of Medicine, 27 Inhang-ro, Jung-gu, Incheon 400-711, Korea. Tel +82-32-890-3659, Fax +82-32-890-3864, Email: seonghye@inha.ac.kr
    Received July 28, 2011; Revised December 20, 2011; Accepted December 20, 2011.

    This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Abstract

    Background and Purpose

    The objective of this study was to determine the benefits of cognitive training in patients with amnestic mild cognitive impairment (aMCI) and those with early Alzheimer's disease (AD).

    Methods

    Eleven patients with aMCI and nine with early AD (stage 4 on the Global Deterioration Scale) participated in this study. Six participants with aMCI and six with AD were allocated to the cognitive training group, while five participants with aMCI and three with AD were allocated to a wait-list control group. Multicomponent cognitive training was administered in 18 weekly, individual sessions. Outcome measures were undertaken at baseline, and at 2 weeks and 3 months of follow-up.

    Results

    In the trained MCI group, there were significant improvements in the delayed-recall scores on the Seoul Verbal Learning Test at both the 2-week and 3-month follow-ups compared with baseline (baseline, 1.6±1.5; 2 weeks, 4.4±1.5, p=0.04; 3 months, 4.6±2.3, p=0.04). The phonemic fluency scores (1.0±0.8 vs. 5.0±1.8, p=0.07) and Korean Mini-Mental State Examination scores (18.8±0.5 vs. 23.8±2.2, p=0.07) also showed a tendency toward improvement at the 2-week follow-up compared to baseline in the trained AD group.

    Conclusions

    This study provides evidence of the effectiveness of cognitive training in aMCI and early AD. The efficacy of cognitive training programs remains to be verified in studies with larger samples and a randomized design.

    Keywords
    Alzheimer's disease; cognitive therapy; memory; mild cognitive impairment; training

    Introduction

    The transitional state between the cognitive changes of normal aging and mild dementia is referred to as mild cognitive impairment (MCI).1 It is a heterogeneous clinical condition with several subtypes and multiple etiologies.2 The amnestic subtype of MCI (aMCI) is defined as a significant impairment in memory with no impairment in the activities of daily living.1 An interventional study of patients meeting the Petersen criteria for aMCI1 found that 16% progress to dementia each year, 99% of whom are ultimately diagnosed with Alzheimer's disease (AD).3 aMCI is often a degenerative condition that may represent prodromal AD.4 Therefore, it is crucial to develop and evaluate treatment strategies for this population. However, no pharmacological treatments are currently available to improve the symptoms or slow down the disease progression in patients with aMCI.3, 5

    Clinicians have been interested in other potential treatment alternatives for patients with aMCI, such as cognitive interventions. Patients with aMCI differ from patients with dementia in terms of their relatively preserved insight6 and metamemory.7 Therefore, cognitive intervention may be a more effective treatment for aMCI than for AD. However, previous studies have failed to show consistently that cognitive intervention is efficacious in aMCI.8-15 Objective measures of memory have revealed statistically significant improvements after cognitive intervention in only approximately one-half of the published studies.8 Furthermore, the subjective measures of memory, quality of life, and mood/anxiety were also statistically improved after cognitive intervention in half of all of the relevant published studies.8 Although follow-up evaluation is crucial for assessing the longitudinal course of the efficacy data because aMCI is a degenerative condition in a certain proportion of individuals, a follow-up evaluation was not conducted in many previous studies.7, 12, 16, 17 Therefore, the efficacy of cognitive intervention programs in aMCI remains to be verified.18

    The effect of cognitive intervention in AD patients is more uncertain.19, 20 One study showed a beneficial effect of a computerized cognitive training program in mild dementia as well as in MCI.12 Since AD is a progressive neurodegenerative disorder, cognitive training may be more effective at the earliest stage of AD, during the time directly after conversion from MCI.

    Cognitive training programs should be adjusted according to the cultural and social background of the patient. To our knowledge there have been no reports of the effects of cognitive training in patients with aMCI or early AD21 in Korea. The objective of this study was to determine the benefits of a multicomponent cognitive training program in patients with aMCI and in those with early AD.

    Methods

    Study participants

    Twenty patients, comprising 11 with aMCI and 9 with early AD, participated in this study. They were recruited consecutively from outpatients visiting a memory clinic in the Department of Neurology at Inha University Hospital between May 2008 and May 2009. The subjects with AD 1) met the criteria for dementia according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition,22 and the criteria for probable AD established by the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association,23 2) had received a stable dose of an acetylcholinesterase inhibitor for at least 8 weeks before the start of the study, and 3) were at stage 4 on the Korean version of the Global Deterioration Scale (GDS).24 aMCI was diagnosed using the criteria defined by Petersen and colleagues:1 1) memory complaint corroborated by an informant, 2) delayed-recall score on the Seoul Verbal Learning Test (SVLT) at or below 1.5 standard deviations from the mean of the age and education-normative values among the Korean population,25 3) at stage 3 on the GDS, 4) at or above 1.5 standard deviations from the mean of normative data of the respective age- and education-matched population on the Korean Mini-Mental State Examination (K-MMSE),26 5) normal functional activities, and 6) not diagnosed with dementia.

    Subjects were 50-80 years of age, were ambulatory, and had brain magnetic resonance imaging scans showing no clinical evidence of other diseases capable of producing cognitive impairment (i.e., normal-pressure hydrocephalus, brain tumor, and cerebrovascular disease). Subjects were also required to have a reliable caregiver who met with the patient at least once a week and could provide the investigator with accurate information about the patient. The doses of psychotropic medication or any drugs able to affect cognition were kept constant throughout the study period among all participants.

    Exclusion criteria included any primary neurodegenerative or psychiatric disorder other than AD (i.e., Parkinson's disease, schizophrenia, or major depressive disorder), clinically significant laboratory abnormalities such as an abnormal thyroid function test, abnormally low level of vitamin B12 or folate, positive venereal disease research laboratory test, any history of drug or alcohol addiction during the past 10 years, any severe or unstable medical disease that could prevent the patient from completing all of the study requirements (i.e., unstable or severe asthma or cardiovascular disease, active gastric ulcer, or severe hepatic or renal disease), any hearing or visual impairment that could significantly impair the evaluation of the patient, illiteracy, and an involvement in other clinical trials or exposure to treatment by any experimental drug within the previous 4 weeks.

    Six participants with aMCI and six with AD were allocated to the cognitive training group, while five with aMCI and three with AD were allocated to a wait-list control group. The study protocol and informed consent form were reviewed and approved by the institutional review board of Inha University Hospital. All subjects gave their written informed consent to participate in the study.

    Cognitive training

    The cognitive training was administered via 18 weekly sessions, at hospital-based outpatient memory clinics. Each session lasted approximately 50 minutes. The cognitive training program, which was offered in the form of individual sessions, was a multicomponent cognitive training program, targeted largely at memory training. There was one instructor, who was an experienced clinical neuropsychologist. The cognitive training program was conducted in a standardized manner, but the difficulty level was individualized.

    In brief, sessions included a welcome and checking-homework period (5 minutes), reality orientation techniques (10 minutes), attentional training (10 minutes), and cognitive exercises (25 minutes). The cognitive exercises were designed to stimulate one specific cognitive function during each session (eight sessions focused on memory, five sessions focused on visuoconstructional abilities, and five sessions focused on executive functions and abstract thinking). The contents of the components of the intervention are described in Table 1. The goal of the sessions was to improve the participants' daily function. Homework was assigned at every session in order to encourage the patients to practice and apply any strategies learned from the program in their daily life.

    Table 1
    Components and content of the cognitive training

    The methods selected for the intervention were reflective of current evidence-based scientific research in cognitive training.7, 10, 16, 27 Strategies for improving organizational and attention skills in learning and remembering were practiced during memory training. The following easily implemented memory strategies that could be used for specific daily tasks (e.g., face-name recall or remembering a story or shopping list) were also practiced: verbal categorization,27 hierarchical organization,10 visual imagery,16 errorless learning,7 finding key words of a story or news item, giving a title to a story or news item, and face-name association.16

    Outcome measures

    Outcome measures were recorded at baseline, and after 2 weeks and 3 months of cognitive training in the trained group, and twice at an interval of 20 weeks in the wait-list control group. Cognition was assessed using the K-MMSE and the Seoul Neuropsychological Screening Battery-dementia version (SNSB-D),25 an extensive neuropsychological test battery including the SVLT of a 12-word list consisting of 4 household items, 4 flowers, and 4 stationery words, the short form of the Korean version of the Boston Naming Test (K-BNT), consisting of 15 black-and-white line drawings, Rey Osterrieth Complex Figure test, digit span forward and backward tests, semantic and phonemic verbal fluency, and the Stroop Color-Word Test. The Korean version of the Quality of Life-AD questionnaire was administered to assess the quality of life of the participants.28

    The Self-Assessment of Cognition questionnaire (SAC) and Satisfaction Questionnaire were administered only to the participants in the trained group. The SAC consists of the following six self-assessment items: 1) I know the date; 2) I recall the name of someone, message for someone, or what I am about to do; 3) I concentrate on some stimuli; 4) I understand what someone is speaking about, book content, or television program; 5) I plan what I have to do and conduct myself to fit the occasion; and 6) I can find my way. The responses for each item were given on the following 5-point scale: 1, 'very impaired'; 2, 'impaired'; 3, 'fair'; 4, 'good'; and 5, 'very good'. The Satisfaction Questionnaire consists of eight items: 1) this program was helpful for reducing anxiety, 2) this program was helpful for adapting to my social life, 3) this program was helpful for gaining confidence, 4) this program was helpful for human relationships, 5) this program was interesting, 6) I will participate in a program like this again, 7) I will recommend this program to others, and 8) my family or friends said that my memory, function or mood was improved after I finished this program. Again, the responses for each item were given on a 5-point scale: 1, 'never'; 2, 'a little'; 3, 'fair'; 4, 'much'; and 5, 'very much'. The SAC and Satisfaction Questionnaire were scored by averaging each participant's ratings (range 1-5), with higher scores indicating greater satisfaction with the training program.

    Statistical analysis

    The patient's demographic and clinical characteristics were compared using the Mann-Whitney U test for continuous variables and Fisher's exact test for categorical variables. The post-training and baseline scores of the outcome measures were compared using the Wilcoxon signed-rank test in each group. The continuous variables measured in this study are expressed as mean±SD values. Statistical analyses were performed using SPSS version 18.0 software. Significance was considered to be present when p<0.05.

    Results

    Group characteristics

    Of the original 20 participants, 17 (85%) completed the final follow-up; 1 participant with aMCI and 2 with AD in the trained group were excluded from the study. The aMCI participant withdrew from participation because the distance from home to hospital was too far, while one of the AD patients dropped out due to an injury sustained in an accident and the other withdrew her consent. The age, gender, educational level, and the K-MMSE score did not differ significantly between the participants who withdrew from the study and their counterparts with aMCI and AD who completed the study. The demographic characteristics and baseline K-MMSE and Korean version of the Geriatric Depression Scale (GDS-K)29 scores are given in Table 2. The age, gender, education level, K-MMSE score, GDS-K score, and baseline scores of each item of the SNSB-D did not differ significantly between the trained group and the control group for either the participants with aMCI or those with AD. The duration of receiving a stable dose of an acetylcholinesterase inhibitor did not differ significantly between the trained AD group and the control group (8.3±0.5 weeks vs. 8.7±1.2 weeks; p=0.86). The AD participants took various acetylcholinesterase inhibitors; however, the mean dosages were about two-thirds of the maximal treatable dosage in both groups and did not differ significantly between them (62.5±25.0% vs. 72.3±25.4%; p=0.63).

    Table 2
    Demographic data of the participant groups (observed cases)

    Outcome variables

    In the trained MCI group, there were significant differences between the delayed-recall scores on the SVLT at baseline and those at both the 2-week and 3-month follow-ups (1.6±1.5 vs. 4.4±1.5, p=0.04; 1.6±1.5 vs. 4.6±2.3, p=0.04) (Table 3, Fig. 1). The immediate recall scores on the Rey Osterrieth Complex Figure (11.9±9.2 vs. 15.8±9.4; p=0.04) and the SAC (3.5±0.7 vs. 4.5±0.5; p=0.04) were significantly improved at the 2-week follow-up in the trained MCI group. There was a tendency toward improvement of the digit span forward scores (6.2±1.1 vs. 7.8±1.3; p=0.07) at the 2-week follow-up and the short-form K-BNT scores (10.6±1.9 vs. 12.0±2.0; p=0.07) at the 3-month follow-up compared to the baseline scores in the trained MCI group (Table 3). The KQOL-AD score was improved after cognitive training, but the difference did not reach statistical significance (23.3±7.5 vs. 27.9±7.7; p=0.23).

    Fig. 1
    Changes in the delayed recall scores on the Seoul Verbal Learning Test (SVLT) (A) and Korean Mini-Mental State Examination (K-MMSE) (B). A: In the trained mild cognitive impairment (MCI) group (♦), the delayed recall scores on the SVLT showed a significant improvement at both the 2-week and 3-month follow-ups compared to the baseline score (1.6±1.5 vs. 4.4±1.5, p=0.04; 1.6±1.5 vs. 4.6±2.3, p=0.04). B: The K-MMSE score showed a tendency to improve at the 2-week follow-up compared to baseline in the trained Alzheimer's disease (AD) group (○; 18.8±0.5 vs. 23.8±2.2, p=0.07).

    Table 3
    Changes in outcome variables in the participants with aMCI

    The short-form K-BNT score had declined significantly at the follow-up examination compared to the baseline score in the MCI wait-list control group (11.2±1.9 vs. 10.0±2.2; p=0.046). There were no significant differences between the baseline and follow-up scores in other outcome measures in the MCI wait-list control group.

    The phonemic fluency (1.0±0.8 vs. 5.0±1.8; p=0.07) and K-MMSE scores (18.8±0.5 vs. 23.8±2.2; p=0.07) exhibited a tendency toward improvement at the 2-week follow-up compared to the baseline scores in the trained AD group (Table 4, Fig. 1). The correct color reading of the Stroop test (13.0±13.1 vs. 29.0±9.4; p=0.07) and calculation scores (4.5±0.6 vs. 6.5±0.6; p=0.07) also exhibited a tendency toward improvement at the 3-month follow-up compared to baseline in the trained AD group (Table 4). The delayed-recall SVLT scores had improved at 2 weeks after cognitive training, but the difference did not reach statistical significance (0.0±0.0 vs. 2.0±2.8; p=0.18) (Table 4). There were no significant differences between the baseline and follow-up scores of any measures in the AD wait-list control group.

    Table 4
    Changes in outcome variables in the participants with early AD

    Discussion

    The findings of this study show that cognitive training is effective in patients with aMCI or early AD. Participants with aMCI in the trained group exhibited a significant improvement in delayed recall of the SVLT after completing the cognitive training program, and improvements in episodic memory were maintained until 3 months after the end of the cognitive training (Table 3, Fig. 1). Cognitive training might therefore delay the conversion from aMCI to dementia. Global cognition was improved after cognitive training in early AD, but it declined slightly after completion of the cognitive training (Table 4, Fig. 1). The early AD patients in the trained group showed a nonsignificant improvement of verbal episodic memory, but this improvement was reduced after the conclusion of cognitive training (Fig. 1).

    Patients with early AD benefited less from cognitive training than did patients with aMCI. There are three likely explanations for modest effects of cognitive training in early AD: 1) the same training programs were applied to the aMCI and AD patients, and hence the level of difficulty of some of the components may have been set too high relative to the cognitive abilities of this group; 2) the absence of a significant difference could have been due to the small sample in this study; and 3) in AD (even early AD), episodic memory is severely impaired, which may make it difficult to improve episodic memory significantly by memory training.

    While a multicomponent cognitive training program was employed in this study, cognitive training was effective on episodic memory in aMCI relative to other cognitive domains. This finding is in accordance with the results of previous studies on the effects of cognitive training in patients with aMCI.8, 11, 16 There are several possible interpretations for this finding. First, the improvement in episodic memory may be due to the memory training in the present study being performed more frequently than training of the other cognitive domains. A second possible interpretation is that the cognitive function of the other domains did not improve significantly after cognitive training because the other cognitive functions (aside from memory) were close to normal in the patients with aMCI.30 A third possible interpretation is that the outcome measures might not be sensitive enough to detect improvements in cognitive functions other than memory because of a ceiling effect of the neuropsychological tests for those other cognitive functions in aMCI. The early AD patients showed improvements in global cognitive status and executive function after cognitive training, and this finding is in accordance with the results of a previous study.12 However, we cannot exclude the possibility that this was a type of transient practice effect. It is therefore crucial to assess the longitudinal course of the efficacy data.

    The training was standardized by having the same instructor administer the training using standardized instructions through all of the sessions in this study. The main advantage of individual programs is tailoring of the training to the needs and complaints of the individual patients. The satisfaction regarding the training program was high among the trained participants. The advantage of the standardized individual training may have contributed to a large improvement in episodic memory in the participants with aMCI. However, the individual training is limited by a single instructor being able to train only a few patients.

    This is a preliminary study, and it has several limitations. First, the patient sample was small. In particular, the number of subjects was smaller in the AD wait-list control group than in the AD trained group. Furthermore, a few of the AD patients agreed to complete the intensive neuropsychological tests without any training, twice with an interval of 20 weeks. This limits the generalizability of the results. Second, this study was not a randomized blind trial. Third, the emotional state of the participants after the training program was not examined. According to some previous studies,11, 12, 15 depressive symptoms improve after cognitive interventions. However, none of the patients in the present study had significant depressive symptoms (GDS-K score ≥18) at baseline. Therefore, the observed improvement in episodic memory may not have been related to a reduction in depressive symptoms. Fourth, the effects of the training on the Instrumental Activities of Daily Living (IADL) score were not examined in this study. Although according to Petersen's criteria daily functioning must be intact in aMCI, there is some evidence that IADL is slightly impaired in aMCI.31 Given that MCI is a potentially degenerative condition, IADL scores are likely to deteriorate over time, at least in some patients with MCI. Therefore, the IADL score may be sensitive to early functional changes related to MCI, and this tool should thus be applied as an outcome measure. There was no improvement in the scores on the Functional Activities Questionnaire after intervention in either MCI or in mild to moderate AD,32 but a previous study showed that daily activities measured using the Bayer Activities of Daily Living scale-which is known to be a sensitive measure in MCI-were improved after cognitive intervention in MCI.15 Fifth, the 3-month follow-up evaluation was not conducted for the control patients.

    Cognitive training had a positive effect on episodic memory in aMCI relative to other cognitive domains. The early AD patients showed improvements in global cognitive status and executive function after cognitive training. However, these findings should be interpreted with caution given the small sample. In conclusion, this study provides evidence of the effectiveness of cognitive training in aMCI and early AD. The efficacy of cognitive training programs remains to be verified in larger samples in randomized studies.

    Notes

    The authors have no financial conflicts of interest.

    Acknowledgements

    This study was supported by grants of the Korea Healthcare technology R&D Project, the Ministry of Health and Welfare, Republic of Korea (A102065), and Inha University.

    References

      1. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–1992.
      1. Busse A, Hensel A, Gühne U, Angermeyer MC, Riedel-Heller SG. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 2006;67:2176–2185.
      1. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379–2388.
      1. Zhang D, Wang Y, Zhou L, Yuan H, Shen D. Alzheimer's Disease Neuroimaging Initiative. Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage 2011;55:856–867.
      1. Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, et al. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology 2009;72:1555–1561.
      1. Kalbe E, Salmon E, Perani D, Holthoff V, Sorbi S, Elsner A, et al. Anosognosia in very mild Alzheimer's disease but not in mild cognitive impairment. Dement Geriatr Cogn Disord 2005;19:349–356.
      1. Akhtar S, Moulin CJ, Bowie PC. Are people with mild cognitive impairment aware of the benefits of errorless learning? Neuropsychol Rehabil 2006;16:329–346.
      1. Jean L, Bergeron ME, Thivierge S, Simard M. Cognitive intervention programs for individuals with mild cognitive impairment: systematic review of the literature. Am J Geriatr Psychiatry 2010;18:281–296.
      1. Unverzagt FW, Kasten L, Johnson KE, Rebok GW, Marsiske M, Koepke KM, et al. Effect of memory impairment on training outcomes in ACTIVE. J Int Neuropsychol Soc 2007;13:953–960.
      1. Rapp S, Brenes G, Marsh AP. Memory enhancement training for older adults with mild cognitive impairment: a preliminary study. Aging Ment Health 2002;6:5–11.
      1. Rozzini L, Costardi D, Chilovi BV, Franzoni S, Trabucchi M, Padovani A. Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. Int J Geriatr Psychiatry 2007;22:356–360.
      1. Talassi E, Guerreschi M, Feriani M, Fedi V, Bianchetti A, Trabucchi M. Effectiveness of a cognitive rehabilitation program in mild dementia (MD) and mild cognitive impairment (MCI): a case control study. Arch Gerontol Geriatr 2007;44 Suppl 1:391–399.
      1. Troyer AK, Murphy KJ, Anderson ND, Moscovitch M, Craik FI. Changing everyday memory behaviour in amnestic mild cognitive impairment: a randomised controlled trial. Neuropsychol Rehabil 2008;18:65–88.
      1. Kinsella GJ, Mullaly E, Rand E, Ong B, Burton C, Price S, et al. Early intervention for mild cognitive impairment: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2009;80:730–736.
      1. Kurz A, Pohl C, Ramsenthaler M, Sorg C. Cognitive rehabilitation in patients with mild cognitive impairment. Int J Geriatr Psychiatry 2009;24:163–168.
      1. Belleville S, Gilbert B, Fontaine F, Gagnon L, Ménard E, Gauthier S. Improvement of episodic memory in persons with mild cognitive impairment and healthy older adults: evidence from a cognitive intervention program. Dement Geriatr Cogn Disord 2006;22:486–499.
      1. Wenisch E, Cantegreil-Kallen I, De Rotrou J, Garrigue P, Moulin F, Batouche F, et al. Cognitive stimulation intervention for elders with mild cognitive impairment compared with normal aged subjects: preliminary results. Aging Clin Exp Res 2007;19:316–322.
      1. Stott J, Spector A. A review of the effectiveness of memory interventions in mild cognitive impairment (MCI). Int Psychogeriatr 2011;23:526–538.
      1. Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev 2003;(4):CD003260.
      1. Sitzer DI, Twamley EW, Jeste DV. Cognitive training in Alzheimer's disease: a meta-analysis of the literature. Acta Psychiatr Scand 2006;114:75–90.
      1. Rami L, Molinuevo JL, Sanchez-Valle R, Bosch B, Villar A. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population. Int J Geriatr Psychiatry 2007;22:294–304.
      1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
      1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–944.
      1. Choi SH, Na DL, Lee BH, Hahm DS, Jeong JH, Jeong Y, et al. The validity of the Korean version of Global Deterioration Scale. J Korean Neurol Assoc 2002;20:612–617.
      1. Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci 2010;25:1071–1076.
      1. Kang YW. A normative study of the Korean-Mini Mental State Examination (K-MMSE) in the elderly. Korean J Psychol Gen 2006;25:1–12.
      1. Craik FI, Winocur G, Palmer H, Binns MA, Edwards M, Bridges K, et al. Cognitive rehabilitation in the elderly: effects on memory. J Int Neuropsychol Soc 2007;13:132–142.
      1. Shin HY. A preliminary study on the Korean version of quality of life-Alzheimer's disease (QOL-AD) scale in community-dwelling elderly with dementia. J Prev Med Public Health 2006;39:243–248.
      1. Bae JN, Cho MJ. Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients. J Psychosom Res 2004;57:297–305.
      1. Collie A, Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev 2000;24:365–374.
      1. Jefferson AL, Byerly LK, Vanderhill S, Lambe S, Wong S, Ozonoff A, et al. Characterization of activities of daily living in individuals with mild cognitive impairment. Am J Geriatr Psychiatry 2008;16:375–383.
      1. Olazarán J, Muñiz R, Reisberg B, Peña-Casanova J, del Ser T, Cruz-Jentoft AJ, et al. Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease. Neurology 2004;63:2348–2353.
    Cited by
    Crossref 22
    Google Scholar 
    PubMed Central 16
    Scopus 29
    Web of Science 24
    MeSH Terms
    Alzheimer Disease
    Cognitive Therapy
    Follow-Up Studies
    Humans
    Memory
    Mild Cognitive Impairment
    Outcome Assessment (Health Care)
    Verbal Learning
    Metrics
    Share
    Links to
    Figures
    slide

    1 / 1

    Tables
    slide
    slide
    slide
    slide

    1 / 4

    PERMALINK